journal
https://read.qxmd.com/read/24851191/syk-as-a-new-therapeutic-target-in-b-cell-precursor-acute-lymphoblastic-leukemia
#21
Fatih M Uckun, Sanjive Qazi
The identification of SYK as a master regulator of apoptosis controlling the activation of the PI3-K/AKT, NFκB, and STAT3 pathways-three major anti-apoptotic signaling pathways in B-lineage leukemia/lymphoma cells-prompts the hypothesis that rationally designed inhibitors targeting SYK may overcome the resistance of malignant B-lineage lymphoid cells to apoptosis and thereby provide the foundation for more effective multi-modality treatment regimens for poor prognosis B-precursor acute lymphoblastic leukemia (BPL)...
January 2014: Journal of Cancer Therapy
https://read.qxmd.com/read/24660091/smoking-and-pancreatic-disease
#22
JOURNAL ARTICLE
Mouad Edderkaoui, Edwin Thrower
Smoking is a major risk factor for chronic pancreatitis and pancreatic cancer. However, the mechanisms through which it causes the diseases remain unknown. In the present manuscript we reviewed the latest knowledge gained on the effect of cigarette smoke and smoking compounds on cell signaling pathways mediating both diseases. We also reviewed the effect of smoking on the pancreatic cell microenvironment including inflammatory cells and stellate cells.
November 1, 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/24563807/cks1-structure-emerging-roles-and-implications-in-multiple-cancers
#23
Vinayak Khattar, Jaideep V Thottassery
Deregulation of the cell cycle results in loss of normal control mechanisms that prevent aberrant cell proliferation and cancer progression. Regulation of the cell cycle is a highly complex process with many layers of control. One of these mechanisms involves timely degradation of CDK inhibitors (CKIs) like p27(Kip1) by the ubiquitin proteasomal system (UPS). Cks1 is a 9 kDa protein which is frequently overexpressed in different tumor subtypes, and has pleiotropic roles in cell cycle progression, many of which remain to be fully characterized...
October 1, 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/24273681/signal-transduction-pathways-mediated-by-secreted-and-non-secreted-forms-of-intact-insulin-like-growth-factor-binding-protein-3-igfbp-3-and-its-1-97-n-terminal-fragment-in-pc-3-human-prostate-cancer-cells
#24
JOURNAL ARTICLE
Hanief M Shahjee, Benjamin Kefas, Nisan Bhattacharyya, Mohamed K Radwan
Our previous results indicated that both the secreted and the intracellular form of full length and 1-97 N-terminal fragment of IGFBP-3 induces apoptosis in PC-3 human prostate cancer cells in an IGF-dependent and independent manner. This study was undertaken to delineate possible down-stream signaling pathways that are involved in this process. Intact IGFBP-3 and its N-terminal 1-97 fragments with or without a signal pro-peptide was fused to YFP and expressed in PC-3 human prostate cancer cells. In some cases, the putative IGF-binding site present in full length IGFBP-3 and its N-terminal fragment was also mutated...
October 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/25068070/the-aryl-hydrocarbon-receptor-a-target-for-breast-cancer-therapy
#25
Joann B Powell, Gennifer D Goode, Sakina E Eltom
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates a battery of genes in response to exposure to a broad class of environmental poly aromatic hydrocarbons (PAH). AhR is historically characterized for its role in mediating the toxicity and adaptive responses to these chemicals, however mounting evidence has established a role for it in ligand-independent physiological processes and pathological conditions, including cancer. The AhR is overexpressed and constitutively activated in advanced breast cancer cases and was shown to drive the progression of breast cancer...
September 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/24511425/saporin-conjugated-monoclonal-antibody-to-the-transcobalamin-receptor-tcblr-cd320-is-effective-in-targeting-and-destroying-cancer-cells
#26
Edward V Quadros, Yasumi Nakayama, Jeffrey M Sequeira
Cobalamin uptake into cells is mediated by the CD320 receptor for transcobalamin-bound cobalamin. Optimum receptor expression is associated with proliferating cells and therefore, in many cancers this receptor expression is up regulated. Delivering drugs or toxins via this receptor provides increased targeting to cancer cells while minimizing toxicity to the normal tissues. Saporin conjugated monoclonal antibodies to the extracellular domain of TCblR were effectively internalized to deliver a toxic dose of Saporin to some cancer cell lines propagating in culture...
July 22, 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/25621179/assessing-colorectal-cancer-screening-behaviors-and-knowledge-among-at-risk-hispanics-in-southern-new-mexico
#27
Janeth I Sanchez, Rebecca Palacios, Beti Thompson, Vanessa Martinez, Mary A O'Connell
PURPOSE: Colorectal cancer (CRC) mortality rates in New Mexico (NM) continue to be higher than national rates. Hispanic CRC mortality rates in NM surpass those of overall Hispanics in the US. This study was designed to characterize and understand factors contributing to low CRC screening rates in this border region. METHODS: A CRC Knowledge Assessment Survey (KAS) was administered in either English or Spanish to 247 individuals attending community events throughout southern NM...
July 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/25285238/nef-m1-a-cxcr4-peptide-antagonist-enhances-apoptosis-and-inhibits-primary-tumor-growth-and-metastasis-in-breast-cancer
#28
JOURNAL ARTICLE
Harvey Bumpers, Ming-Bo Huang, Venkat Katkoori, Upender Manne, Vincent Bond
Results from studies with animal models suggest that, in many cancers, CXCR4 is an important therapeutic target and that CXCR4 antagonists may be promising treatments for primary cancers and for metastases. The Nef protein effectively competes with CXCR4's natural ligand, SDF-1α, and induces apoptosis. As described in this report, the Nef-M1 peptide (Nef protein amino acids 50 - 60) inhibits primary tumor growth and metastasis of breast cancer (BC). Four BC cell lines (MDA-MB-231, MDA-MB-468, MCF 7, and DU4475) and primary human mammary epithelium (HME) cells were evaluated for their response to the Nef protein and to the Nef-M1 peptide...
June 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/25057429/nucleic-acid-aptamers-as-potential-therapeutic-and-diagnostic-agents-for-lymphoma
#29
JOURNAL ARTICLE
Ka-To Shum, Jiehua Zhou, John J Rossi
Lymphomas are cancers that arise from white blood cells and usually present as solid tumors. Treatment of lymphoma often involves chemotherapy, and can also include radiotherapy and/or bone marrow transplantation. There is an un-questioned need for more effective therapies and diagnostic tool for lymphoma. Aptamers are single stranded DNA or RNA oligonucleotides whose three-dimensional structures are dictated by their sequences. The immense diversity in function and structure of nucleic acids enable numerous aptamers to be generated through an iterative in vitro selection technique known as Systematic Evolution of Ligands by EXponential enrichment (SELEX)...
June 1, 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/23946891/expression-of-o-6-methylguanine-dna-methyltransferase-examined-by-alkyl-transfer-assays-methylation-specific-pcr-and-western-blots-in-tumors-and-matched-normal-tissue
#30
Kimiko Ishiguro, Krishnamurthy Shyam, Philip G Penketh, Raymond P Baumann, Alan C Sartorelli, Thomas J Rutherford, Elena S Ratner
The tumor selectivity of alkylating agents that produce guanine O (6)-chloroethyl (laromustine and carmustine) and O (6)-methyl (temozolomide) lesions, depends upon O (6)-methylguanine-DNA methyltransferase (MGMT) activity being lower in tumor than in host tissue. Despite the established role of MGMT as a tumor resistance factor, consensus on how to assess MGMT expression in clinical samples is unsettled. The aim of this study is to examine the relationship between the values derived from distinctive MGMT measurements in 13, 12, 6 and 2 pairs of human tumors and matched normal adjacent tissue from the colon, kidney, lung and liver, respectively, and in human cell lines...
June 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/24163781/correlation-of-transcription-of-malat-1-a-novel-noncoding-rna-with-deregulated-expression-of-tumor-suppressor-p53-in-small-dna-tumor-virus-models
#31
Liesl K Jeffers, Kaiwen Duan, Lesley G Ellies, William T Seaman, Raquel A Burger-Calderon, Luda B Diatchenko, Jennifer Webster-Cyriaque
Although metastasis-associated lung adenocarcinoma transcript (MALAT)-1 is known to be consistently upregulated in several epithelial malignancies, little is known about its function or regulation. We therefore examined the relationship between MALAT-1 expression and candidate modulators such as DNA tumor virus oncoproteins human papillomavirus (HPV)-16 E6 and E7, BK virus T antigen (BKVTAg), mouse polyoma virus middle T antigen (MPVmTAg) and tumor suppressor genes p53 and pRb. Using suppressive subtractive hybridization (SSH) and real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays, MALAT-1 was shown to be increased in viral oncongene-expressing salivary gland biopsies from humans and mice...
May 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/24089656/a-study-of-zoledronic-acid-as-neo-adjuvant-perioperative-therapy-in-patients-with-resectable-pancreatic-ductal-adenocarcinoma
#32
JOURNAL ARTICLE
Dominic E Sanford, Matthew R Porembka, Roheena Z Panni, Jonathan B Mitchem, Brian A Belt, Stacey M Plambeck-Suess, Goldie Lin, David G Denardo, Ryan C Fields, William G Hawkins, Steven M Strasberg, A Craig Lockhart, Andrea Wang-Gillam, Simon Peter Goedegebuure, David C Linehan
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by abundant granulocytic myeloid-derived suppressor cells (G-MDSC = CD45(+)/Lin(-)/CD33(+)/CD11b(+)/CD15(+)), which infiltrate tumors and suppress anti-tumor immunity. We have previously demonstrated in a murine model of PDAC that zoledronic acid (ZA) depletes G-MDSC resulting in decreased tumor growth and improved survival. We report here the results of a phase 1 clinical trial (NCT00892242) using ZA as neo-adjuvant, perioperative therapy in patients with non-metastatic, resectable pancreatic adenocarcinoma...
May 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/26877888/targeting-of-androgen-receptor-expression-by-andro-mirs-as-novel-adjunctive-therapeutics-in-prostate-cancer
#33
Jey Sabith Ebron, Crystal M Weyman, Girish C Shukla
Prostate cancer begins as an androgen-responsive disease. However, subsequent accumulation of multiple sequential genetic and epigenetic alterations transforms the disease into an aggressive, castration-resistant prostate cancer (CRPC). The monoallelic Androgen Receptor (AR) is associated with the onset, growth and development of Prostate cancer. The AR is a ligand-dependent transcription factor, and the targeting of androgen- and AR-signaling axis remains the primary therapeutic option for Prostate cancer (PCa) treatment...
April 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/24683497/the-effect-of-fasting-on-pet-imaging-of-hepatocellular-carcinoma
#34
JOURNAL ARTICLE
Nathan Tenley, David J Corn, Lewis Yuan, Zhenghong Lee
The clinical utility of positron emission tomography (PET) imaging for liver cancer applications is not clearly defined either for diagnosis or treatment assessment. Previous clinical studies demonstrated that fluorodeoxyglucose (FDG) did not show uptake in some hepatocellular carcinoma (HCC) while acetate showed uptake. Pre-imaging fasting is required for clinical PET imaging with FDG. No studies were done to confirm the effect of fasting on acetate uptake in HCC for PET imaging. We investigated this situation with a woodchuck model of viral infection-induced HCC...
April 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/23875116/adenocarcinomas-after-prophylactic-surgery-for-familial-adenomatous-polyposis
#35
Joan C Smith, Michael W Schäffer, Billy R Ballard, Duane T Smoot, Alan J Herline, Samuel E Adunyah, Amosy E M'koma
The incidence of familial adenomatous polyposis (FAP) is one in 7,000 to 12,000 live births. Virtually, all surgically untreated patients with FAP inevitably develop colorectal-cancer in their lifetime because they carry the adenomatous polyposis coli gene. Thus prophylactic proctocolectomy is indicated. Surgical treatment of FAP is still controversial. There are however, four surgical options: ileorectal anastomosis, restorative proctocolectomy with ileal pouch-anal anastomosis, proctocolectomy with ileostomy, and proctocolectomy with continent-ileostomy...
2013: Journal of Cancer Therapy
https://read.qxmd.com/read/23741626/plga-polymer-encapsulating-tumor-antigen-and-cpg-dna-administered-into-the-tumor-microenvironment-elicits-a-systemic-antigen-specific-ifn-%C3%AE-response-and-enhances-survival
#36
Kevin P Nikitczuk, Rene S Schloss, Martin L Yarmush, Edmund C Lattime
Critical to the generation of an effective therapeutic antitumor immune response is the elicitation of effective antigen presentation coupled with overcoming tumor-immune escape mechanisms. Towards this end, we aimed to understand the therapeutic effectiveness of a polymer based vaccine approach at enhancing the anti-tumor responses in a tumor-bearing mouse model. While we and others have previously demonstrated the effectiveness of PLGA based systems in delivering antigen etc., studies scarcely focus on understanding the immunological mechanisms of polymer based therapies in tumor bearing treatment models...
January 1, 2013: Journal of Cancer Therapy
https://read.qxmd.com/read/23560242/diabetes-mellitus-and-colorectal-neoplasia
#37
Alejandro Acevedo, Yaritza Diaz, Cynthia M Perez, Maria Garau, John Baron, Marcia Cruz-Correa
BACKGROUND: Many studies have provided evidence for an association between obesity, physical inactivity, and western diet as risk factors for colorectal cancer (CRC). Few studies directly address the association between type 2 Diabetes Mellitus (DM) and the risk of colorectal lesions at specific anatomic locations. METHODS: 2,663 subjects with a previous history of adenoma(s) and removal of all current adenomas at study entry were followed for a mean time of three years across three different chemoprevention clinical trials...
November 1, 2012: Journal of Cancer Therapy
https://read.qxmd.com/read/26225216/synthesis-of-gemcitabine-c4-amide-anti-her2-neu-utilizing-a-uv-photoactivated-gemcitabine-intermediate-cytotoxic-anti-neoplastic-activity-against-chemotherapeutic-resistant-mammary-adenocarcinoma-skbr-3
#38
Cody P Coyne, Toni Jones, Ryan Bear
Gemcitabine is a pyrimidine nucleoside analog that becomes triphosphorylated intracellularly where it competitively inhibits cytidine incorporation into DNA strands. Another mechanism-of-action of gemcitabine (diphosphorylated form) involves irreversible inhibition of the enzyme ribonucleotide reductase thereby preventing deoxyribonucleotide synthesis. Functioning as a potent chemotherapeutic gemcitabine promote decreases in neoplastic cell proliferation and apoptosis which is frequently found to be effective for the treatment of several leukemias and a wide spectrum of carcinomas...
October 2012: Journal of Cancer Therapy
https://read.qxmd.com/read/25893133/human-gm3-synthase-attenuates-taxol-triggered-apoptosis-associated-with-downregulation-of-caspase-3-in-ovarian-cancer-cells
#39
Su Huang, Khadijeh Bijangi-Vishehsaraei, Mohammad Reza Saadatzadeh, Ahmad R Safa
BACKGROUND: Taxol (paclitaxel) inhibits proliferation and induces apoptosis in a variety of cancer cells, but it also upregulates cytoprotective proteins and/or pathways that compromise its therapeutic efficacy. MATERIALS AND METHOD: The roles of GM3 synthase (α2,3-sialyltransferase, ST3Gal V) in attenuating Taxol-induced apoptosis and triggering drug resistance were determined by cloning and overexpressing this enzyme in the SKOV3 human ovarian cancer cell line, treating SKOV3 and the transfectants (SKOV3/GS) with Taxol and determining apoptosis, cell survival, clonogenic ability, and caspase-3 activation...
October 2012: Journal of Cancer Therapy
https://read.qxmd.com/read/24236248/safety-and-feasibility-of-topical-application-of-limonene-as-a-massage-oil-to-the-breast
#40
Jessica A Miller, Patricia A Thompson, Iman A Hakim, Ana Maria Lopez, Cynthia A Thomson, Wade Chew, Chiu-Hsieh Hsu, H-H Sherry Chow
BACKGROUND: Limonene, a major component in citrus oil, has demonstrated anti-cancer effects in preclinical mammary cancer models. However, the effective oral dose translates to a human dose that may not be feasible for chronic dosing. We proposed to evaluate topical application of limonene to the breast as an alternative dosing strategy. MATERIALS AND METHODS: We conducted a mouse disposition study to determine whether limonene would be bio available in the mammary tissue after topical application...
October 2012: Journal of Cancer Therapy
journal
journal
43484
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.